Comparison of Sildenafil and Tadalafil in the treatment of benign prostatic hyperplasia
Phase 2
- Conditions
- Benign prostatic hyperplasia (BPH).Enlarged prostate with lower urinary tract symptomsN40.1
- Registration Number
- IRCT20210925052576N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 66
Inclusion Criteria
Diagnosed with Benign Prostatic Hyperplasia (BPH) with lower urinary tract symptoms(LUTS)
No prior history of other treatments in last month
Exclusion Criteria
Unwilling to take part in the study
Concurrent treatment with Nitrates
History of cardiac diseases or hypotension
History of prostate surgery
History of Lumbar discopathy or prior herniated disc surgery
History of extensive pelvic or perineal surgeries
Being a known case of neurogenic bladder or presence of its symptoms
Having an active urinary tract infection (UTI)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method